|
|
Volumn 354, Issue 24, 2006, Pages 2621-2622
|
|
Doxycycline treatment for lymphangioleiomyomatosis with urinary monitoring for MMPs [16]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BIOLOGICAL MARKER;
DOXYCYCLINE;
GELATINASE A;
GELATINASE B;
LIPOCALIN;
MATRIX METALLOPROTEINASE;
CELL PROLIFERATION;
DISEASE COURSE;
DOSE RESPONSE;
DRUG TOLERABILITY;
ENZYME REGULATION;
ENZYMURIA;
FORCED EXPIRATORY VOLUME;
HEMANGIOMATOSIS;
HORMONAL THERAPY;
HUMAN;
LETTER;
LUNG CAPACITY;
LUNG CAPILLARY;
LUNG FUNCTION;
LUNG PARENCHYMA;
LUNG TRANSPLANTATION;
LYMPHANGIOLEIOMYOMATOSIS;
OXYGEN SATURATION;
PATIENT MONITORING;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
PROTEIN EXPRESSION;
QUALITY OF LIFE;
RESPIRATORY FAILURE;
SMOOTH MUSCLE FIBER;
SURVIVAL TIME;
TREATMENT OUTCOME;
UPREGULATION;
URINE;
AGED;
ANTI-BACTERIAL AGENTS;
BIOLOGICAL MARKERS;
DOXYCYCLINE;
DRUG MONITORING;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
LYMPHANGIOLEIOMYOMATOSIS;
MATRIX METALLOPROTEINASES;
|
|
EID: 33745091255
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc053410 Document Type: Letter |
|
Times cited : (121)
|
|
References (5)
|
